Canada: 2023 Highlights in Canadian Life Sciences IP and Regulatory Law - Smart & Biggar
Monday, 15 January 2024
Eli Lilly v Teva, Pharmascience, Riva, Apotex, Mylan (tadalafil, CIALIS) – Following a summary trial, Lilly's infringement actions were dismissed: composition claims directed to "a physiologically acceptable salt"...
|
||||
You Might Like |
||||
